查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1379114

呼吸道合胞病毒 (RSV) 診斷市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Respiratory Syncytial Virus (RSV) Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

概要

2022 年，全球呼吸道合胞病毒 (RSV) 診斷市場規模達到 9.2 億美元。展望未來， IMARC Group預計，到 2028 年，該市場將達到 15.68 億美元，2022-2028 年複合年成長率 (CAGR) 為9.3%。

呼吸道合胞病毒（RSV）是一種肺部和呼吸道的病毒感染，可導致氣喘、住院、肺炎、反覆感染、中耳感染和死亡。可以透過驗血、胸部 X 光檢查、分泌物拭子和脈搏血氧飽和度檢查肺部發炎、白血球 (WBC) 計數和血液中的含氧量等體徵來診斷。 RSV 的一些常用治療方案包括非處方 (OTC) 藥物、靜脈 (IV) 液體、濕化氧氣、機械通氣和吸入支氣管擴張劑。

呼吸道合胞病毒 (RSV) 診斷市場趨勢：

RSV 感染在新生兒期可能更為嚴重，因為兩歲以下的兒童往往會出現嚴重的呼吸道症狀。這與家長對兒童醫療照護的日益關注相結合，是促進市場成長的關鍵因素之一。此外，早期診斷後的高存活率和易於獲得的診斷方式也是其他生長誘導因素。除此之外，醫療基礎設施的改善和住院嬰兒治療的優惠報銷政策也促進了市場的成長。此外，生物和奈米技術等先進技術的出現正在促進 RSV 現代檢測系統的發展，例如蛋白質印跡、酶聯免疫吸附測定 (ELISA)、直接免疫螢光和即時聚合酶鏈反應 (PCR) 。除此之外，許多國家的管理機構正在資助研發（R＆D）計畫以開發新療法。預計推動市場的其他因素包括臨床疫苗試驗數量的不斷增加、體外診斷需求的不斷增加、兒童肺炎發病率的上升以及分子診斷的日益採用。

本報告回答的關鍵問題：

  • 迄今為止，全球呼吸道合胞病毒 (RSV) 診斷市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球呼吸道合胞病毒 (RSV) 診斷市場有何影響？
  • 主要區域市場有哪些？
  • 基於產品的市場區隔是什麼？
  • 根據最終用途分類的市場是怎樣的？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球呼吸道合胞病毒（RSV）診斷市場的結構如何？誰是主要參與者？
  • 產業競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球呼吸道合胞病毒 (RSV) 診斷市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按產品分類的市場區隔

  • 直接螢光抗體 (DFA) 方法
    • 市場走向
    • 市場預測
  • 快速抗原診斷測試 (RADT)
    • 市場走向
    • 市場預測
  • 分子診斷
    • 市場走向
    • 市場預測
  • 色譜免疫分析
    • 市場走向
    • 市場預測
  • 診斷影像
    • 市場走向
    • 市場預測
  • 凝膠微滴
    • 市場走向
    • 市場預測
  • 流式細胞儀
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：依最終用途分類的市場區隔

  • 醫院和診所
    • 市場走向
    • 市場預測
  • 實驗室
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Coris BioConcept
    • DiaSorin Molecular LLC (DiaSorin Inc)
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Quest Diagnostics Incorporated
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A4048

Abstract

The global respiratory syncytial virus (RSV) diagnostics market size reached US$ 920 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,568 Million by 2028 exhibiting a growth rate (CAGR) of 9.3% during 2022-2028.

Respiratory syncytial virus (RSV) is a viral infection of the lungs and respiratory tract, which can cause asthma, hospitalization, pneumonia, repeated infections, middle ear infection, and death. It can be diagnosed using blood tests, chest x-rays, a swab of secretions, and pulse oximetry by checking for signs like lung inflammation, white blood cell (WBC) count, and oxygen levels in the blood. Some of the commonly available treatment options for RSV are over-the-counter (OTC) medications, intravenous (IV) fluids, humidified oxygen, mechanical ventilation, and inhaled bronchodilators.

Respiratory Syncytial Virus (RSV) Diagnostics Market Trends:

RSV infection can be more serious during the neonatal period as children under two years of age tend to develop severe respiratory symptoms. This, in confluence with the rising focus of parents on child medical care, represents one of the crucial factors fostering the growth of the market. Moreover, the high survival rates after early diagnosis and the easy availability of diagnostic modalities act as other growth-inducing factors. Apart from this, the improving healthcare infrastructure and favorable reimbursement policies for the treatment of hospitalized infants are also contributing to market growth. Furthermore, the advent of advanced techniques like bio- and nanotechnology is facilitating the development of modern detection systems for RSV, such as western blot, enzyme-linked immunosorbent assay (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR). Besides this, governing agencies of numerous countries are funding research and development (R&D) projects for the development of new therapeutics. Other factors projected to drive the market are the growing number of clinical vaccine trials, the escalating demand for in-vitro diagnostics, rising incidences of childhood pneumonia and the increasing adoption of molecular diagnostics.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory syncytial virus (RSV) diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and end use.

Breakup by Product:

Direct Fluorescent Antibody (DFA) Method

Rapid Antigen Diagnostic Test (RADTs)

Molecular Diagnostics

Chromatographic Immunoassay

Diagnostic Imaging

Gel Microdroplets

Flow Cytometry

Others

Breakup by End Use:

Hospitals and Clinics

Laboratory

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Coris BioConcept, DiaSorin Molecular LLC (DiaSorin Inc), F. Hoffmann-La Roche AG, Merck KGaA, Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global respiratory syncytial virus (RSV) diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global respiratory syncytial virus (RSV) diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global respiratory syncytial virus (RSV) diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Direct Fluorescent Antibody (DFA) Method
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Rapid Antigen Diagnostic Test (RADTs)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Molecular Diagnostics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Chromatographic Immunoassay
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Diagnostic Imaging
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Gel Microdroplets
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Flow Cytometry
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by End Use

  • 7.1 Hospitals and Clinics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Laboratory
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Becton, Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 bioMerieux SA
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bio-Rad Laboratories Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Coris BioConcept
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 DiaSorin Molecular LLC (DiaSorin Inc)
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 F. Hoffmann-La Roche AG
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 SWOT Analysis
    • 13.3.8 Merck KGaA
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Quest Diagnostics Incorporated
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Quidel Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Thermo Fisher Scientific Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Respiratory Syncytial Virus Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by End Use (in %), 2022
  • Figure 6: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: North America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: North America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: United States: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: United States: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Canada: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Canada: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: China: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: China: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Japan: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Japan: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: India: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: India: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: South Korea: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: South Korea: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Australia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Australia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Indonesia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Indonesia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Europe: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Europe: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Germany: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Germany: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: France: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: France: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: United Kingdom: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: United Kingdom: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Italy: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Italy: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Spain: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Spain: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Russia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Russia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Latin America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Latin America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Brazil: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Brazil: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Mexico: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Mexico: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Breakup by Country (in %), 2022
  • Figure 77: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Global: Respiratory Syncytial Virus Diagnostics Industry: SWOT Analysis
  • Figure 79: Global: Respiratory Syncytial Virus Diagnostics Industry: Value Chain Analysis
  • Figure 80: Global: Respiratory Syncytial Virus Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Respiratory Syncytial Virus Diagnostics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 4: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Respiratory Syncytial Virus Diagnostics Market: Competitive Structure
  • Table 6: Global: Respiratory Syncytial Virus Diagnostics Market: Key Players